Drug Type Small molecule drug |
Synonyms MIPS-9922 |
Target |
Action inhibitors |
Mechanism PI3Kβ inhibitors(Phosphatidylinositol 3 kinase beta inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC28H31F2N9O2 |
InChIKeyVOPWCDJBVPMVLJ-FQEVSTJZSA-N |
CAS Registry1416956-33-6 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Thrombosis | Preclinical | Australia | 01 Oct 2016 |





